Hongbing He, PhD

Founder & CEO, Shanghai P & P Biotech Co., Ltd.

Prof. He received his BSc in 1983 in Fudan University, China and his MSc degree in 1988 in Second Military Medical University of PLA, China. From 1988 to 2006, he worked as a surgeon in general surgery in First Military Medical University, China; During this period of time, he also worked as a visiting researcher in the tissue engineering of arteries in Department of Thoracic and Cardiovascular surgery, General Hospital Wels ,Wels, Austria(1992-1993) , Department of Thoracic and Cardiovascular Surgery, Hospital Lainz , Vienna, Austria (1993-1994) , Department of Biomedical Engineering, National Cardiovascular Center, Osaka, Japan(1998-2001). Prof. He has 30 peer reviewed papers besides 4 authorized patents and 12 pending patents.  He also had been selected as a committee member of National Standards Technical Committee of Biological Evaluation of Medical Devices (SAC/TC 248)(from 1999 till now) and a committee member of Chinese Vascular Surgery and Tissue Engineering Committee (from 2010 till now).

Novel Superhydraphilic P(LLA-CL)/Fibrinogen Electrospun Scaffold for Tissue Regeneration

Abstract: A novel superhydrophilic hybrid scaffold was created by electrospinning a mixture of P(LLA-CL) and formulated fibrinogen. The hybrid scaffolds possess the combined benefits of each individual component such as moderate mechanical strength, excellent biocompatibility. Animal experiments for replacement of canine/porcine/rat arteries_Atendons and abdominal walls had been performed. Histological results revealed a promoting transforming process in vivo. The clinical trials for the anterior pelvic floor reconstruction and hernia repair are being conducted, Initial results are also encouraging.